Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Osteoporosis: HELP
Amy H. Warriner
Based on 18 articles published since 2008
||||
Expertise Level
The expertise of Amy H. Warriner ranks in the
  • Top 0.16%
  • ... of 60,762 published authors worldwide on Osteoporosis
  • ... from 2008 through 2019
  • ... based on contributions to 18 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Warriner, Amy H   ·   Warriner, A   ·   Warriner, A H   ·   Warriner, Amy
Work Locations
Details
Most likely:    University of Alabama Birmingham   Contact    
2017
  • Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. · Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA. · New Mexico Clinical Research and Osteoporosis Center, Albuquerque, NM, USA. · Rheumatology Associates of North Alabama, Huntsville, AL, USA. · Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA. · Deparment of Health Care Organization and Policy, University of Alabama at Birmingham, Birmingham, AL, USA. · Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. · Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 28540506
2015
  • From the Division of Endocrinology, Diabetes and Metabolism, and Division of Clinical Immunology and Rheumatology, and Department of Biostatistics, and Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts; Express Scripts, St. Louis, Missouri; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey; Real Endpoints LLC, Westport, Connecticut, USA.A.H. Warriner, MD, Division of Endocrinology, Diabetes and Metabolism; R.C. Outman, MS, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; J.J. Allison, MD, MS, Department of Quantitative Health Sciences, University of Massachusetts Medical School; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; N.J. Markward, PhD, Express Scripts; D.T. Redden, PhD, Department of Biostatistics; M.M. Safford, MD, Division of Preventive Medicine, University of Alabama at Birmingham; E.J. Stanek, PharmD, Novartis Pharmaceuticals Corporation; A.R. Steinkellner, PharmD, Express Scripts* and Real Endpoints LLC; K.G. Saag, MD, MSc, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham. · Pubmed 26136484
2014
  • Department of Medicine, University of Alabama at Birmingham School of Medicine, 908 20th Street South, CCB Room 330A, Birmingham, AL 35294, USA. · Department of Medicine, University of Alabama at Birmingham School of Medicine, 908 20th Street South, CCB Room 330A, Birmingham, AL 35294, USA. Electronic address: · Pubmed 25151566
  • Division of Endocrinology, Metabolism and Diabetes, University of Alabama at Birmingham, FOT 702, 2000 6th Avenue South, Birmingham, AL, 35233-0271, USA, · Pubmed 25064454
  • Divisions of *Endocrinology, Diabetes and Metabolism †Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL ‡Kaiser Permanente Center for Health Research/Northwest, Portland, OR §Kaiser Permanente Center for Health Research/Southeast, Atlanta, GA ∥Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA ¶Division of Clinical Immunology and Rheumatology #Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL. · Pubmed 24984211
2013
  • aDivision of Endocrinology, Metabolism and Diabetes bDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Pubmed 24468753
  • Division of Endocrinology, Metabolism and Diabetes, University of Alabama at Birmingham, 702 Faculty Office Tower, 510 20th Street South, Birmingham, AL, 35233, USA, · Pubmed 24097304
  • Division of Endocrinology, Metabolism and Diabetes, University of Alabama at Birmingham, Birmingham, AL 35233, USA. · Pubmed 23544819
2012
  • Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL 35294, USA. · Pubmed 22836812
2011
  • Division of Endocrinology, Metabolism and Diabetes, The University of Alabama at Birmingham, Birmingham, AL 35233, USA. · Pubmed 21130353
2010
  • Division of Endocrinology, Metabolism, and Diabetes, University of Alabama at Birmingham, FOT 702, 2000 6th Avenue South, Birmingham, AL 35233-0271, USA. · Pubmed 20425517
2009
  • Division of Endocrinology and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Pubmed 19412103
  • University of Alabama at Birmingham, USA. · Pubmed 19279529
2013
  • Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA. · Pubmed 23656714
2010
  • Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. · Pubmed 20889095
2008
  • Center for Education and Research on Therapeutics (CERTs) of Musculoskeletal Disorders, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 820 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35294-3708, USA. · Pubmed 18460267
Probable:    University of Massachusetts Worcester   Contact    
2015
  • From the Division of Endocrinology, Diabetes and Metabolism, and Division of Clinical Immunology and Rheumatology, and Department of Biostatistics, and Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts; Express Scripts, St. Louis, Missouri; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey; Real Endpoints LLC, Westport, Connecticut, USA.A.H. Warriner, MD, Division of Endocrinology, Diabetes and Metabolism; R.C. Outman, MS, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; J.J. Allison, MD, MS, Department of Quantitative Health Sciences, University of Massachusetts Medical School; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; N.J. Markward, PhD, Express Scripts; D.T. Redden, PhD, Department of Biostatistics; M.M. Safford, MD, Division of Preventive Medicine, University of Alabama at Birmingham; E.J. Stanek, PharmD, Novartis Pharmaceuticals Corporation; A.R. Steinkellner, PharmD, Express Scripts* and Real Endpoints LLC; K.G. Saag, MD, MSc, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham. · Pubmed 26136484
2014
  • Divisions of *Endocrinology, Diabetes and Metabolism †Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL ‡Kaiser Permanente Center for Health Research/Northwest, Portland, OR §Kaiser Permanente Center for Health Research/Southeast, Atlanta, GA ∥Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA ¶Division of Clinical Immunology and Rheumatology #Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL. · Pubmed 24984211
Probable:    Novartis      
2015
  • From the Division of Endocrinology, Diabetes and Metabolism, and Division of Clinical Immunology and Rheumatology, and Department of Biostatistics, and Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts; Express Scripts, St. Louis, Missouri; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey; Real Endpoints LLC, Westport, Connecticut, USA.A.H. Warriner, MD, Division of Endocrinology, Diabetes and Metabolism; R.C. Outman, MS, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; J.J. Allison, MD, MS, Department of Quantitative Health Sciences, University of Massachusetts Medical School; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; N.J. Markward, PhD, Express Scripts; D.T. Redden, PhD, Department of Biostatistics; M.M. Safford, MD, Division of Preventive Medicine, University of Alabama at Birmingham; E.J. Stanek, PharmD, Novartis Pharmaceuticals Corporation; A.R. Steinkellner, PharmD, Express Scripts* and Real Endpoints LLC; K.G. Saag, MD, MSc, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham. · Pubmed 26136484
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 18 total) written by Amy H. Warriner about Osteoporosis:

  • Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study. 2017
  • Pharmacologic approaches to the prevention and management of low bone mineral density in HIV-infected patients. 2016
  • An Internet-based Controlled Trial Aimed to Improve Osteoporosis Prevention among Chronic Glucocorticoid Users. 2015
  • HIV-related metabolic comorbidities in the current ART era. 2014
  • Bone alterations associated with HIV. 2014
  • Effect of self-referral on bone mineral density testing and osteoporosis treatment. 2014
  • Challenges in defining quality of care for glucocorticoid-induced osteoporosis: defending good against perfect. 2013
  • Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids. 2013
  • Prevention and treatment of bone changes associated with exposure to glucocorticoids. 2013
  • Study design considerations for a large simple trial of bisphosphonates. 2013
Show List of Full Article Records
Google Searches

Learn more about Amy H. Warriner using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Alabama Birmingham
University of Massachusetts Worcester
Novartis
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Alabama Birmingham
2017
  • Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. · Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA. · New Mexico Clinical Research and Osteoporosis Center, Albuquerque, NM, USA. · Rheumatology Associates of North Alabama, Huntsville, AL, USA. · Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA. · Deparment of Health Care Organization and Policy, University of Alabama at Birmingham, Birmingham, AL, USA. · Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. · Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 28540506
2015
  • From the Division of Endocrinology, Diabetes and Metabolism, and Division of Clinical Immunology and Rheumatology, and Department of Biostatistics, and Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts; Express Scripts, St. Louis, Missouri; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey; Real Endpoints LLC, Westport, Connecticut, USA.A.H. Warriner, MD, Division of Endocrinology, Diabetes and Metabolism; R.C. Outman, MS, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; J.J. Allison, MD, MS, Department of Quantitative Health Sciences, University of Massachusetts Medical School; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; N.J. Markward, PhD, Express Scripts; D.T. Redden, PhD, Department of Biostatistics; M.M. Safford, MD, Division of Preventive Medicine, University of Alabama at Birmingham; E.J. Stanek, PharmD, Novartis Pharmaceuticals Corporation; A.R. Steinkellner, PharmD, Express Scripts* and Real Endpoints LLC; K.G. Saag, MD, MSc, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham. · Pubmed 26136484
2014
  • Department of Medicine, University of Alabama at Birmingham School of Medicine, 908 20th Street South, CCB Room 330A, Birmingham, AL 35294, USA. · Department of Medicine, University of Alabama at Birmingham School of Medicine, 908 20th Street South, CCB Room 330A, Birmingham, AL 35294, USA. Electronic address: · Pubmed 25151566
  • Division of Endocrinology, Metabolism and Diabetes, University of Alabama at Birmingham, FOT 702, 2000 6th Avenue South, Birmingham, AL, 35233-0271, USA, · Pubmed 25064454
  • Divisions of *Endocrinology, Diabetes and Metabolism †Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL ‡Kaiser Permanente Center for Health Research/Northwest, Portland, OR §Kaiser Permanente Center for Health Research/Southeast, Atlanta, GA ∥Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA ¶Division of Clinical Immunology and Rheumatology #Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL. · Pubmed 24984211
2013
  • aDivision of Endocrinology, Metabolism and Diabetes bDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Pubmed 24468753
  • Division of Endocrinology, Metabolism and Diabetes, University of Alabama at Birmingham, 702 Faculty Office Tower, 510 20th Street South, Birmingham, AL, 35233, USA, · Pubmed 24097304
  • Division of Endocrinology, Metabolism and Diabetes, University of Alabama at Birmingham, Birmingham, AL 35233, USA. · Pubmed 23544819
2012
  • Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL 35294, USA. · Pubmed 22836812
2011
  • Division of Endocrinology, Metabolism and Diabetes, The University of Alabama at Birmingham, Birmingham, AL 35233, USA. · Pubmed 21130353
2010
  • Division of Endocrinology, Metabolism, and Diabetes, University of Alabama at Birmingham, FOT 702, 2000 6th Avenue South, Birmingham, AL 35233-0271, USA. · Pubmed 20425517
2009
  • Division of Endocrinology and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama, USA. · Pubmed 19412103
  • University of Alabama at Birmingham, USA. · Pubmed 19279529
2013
  • Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA. · Pubmed 23656714
2010
  • Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. · Pubmed 20889095
2008
  • Center for Education and Research on Therapeutics (CERTs) of Musculoskeletal Disorders, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, 820 Faculty Office Tower, 510 20th Street South, Birmingham, AL 35294-3708, USA. · Pubmed 18460267
University of Massachusetts Worcester
2015
  • From the Division of Endocrinology, Diabetes and Metabolism, and Division of Clinical Immunology and Rheumatology, and Department of Biostatistics, and Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts; Express Scripts, St. Louis, Missouri; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey; Real Endpoints LLC, Westport, Connecticut, USA.A.H. Warriner, MD, Division of Endocrinology, Diabetes and Metabolism; R.C. Outman, MS, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; J.J. Allison, MD, MS, Department of Quantitative Health Sciences, University of Massachusetts Medical School; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; N.J. Markward, PhD, Express Scripts; D.T. Redden, PhD, Department of Biostatistics; M.M. Safford, MD, Division of Preventive Medicine, University of Alabama at Birmingham; E.J. Stanek, PharmD, Novartis Pharmaceuticals Corporation; A.R. Steinkellner, PharmD, Express Scripts* and Real Endpoints LLC; K.G. Saag, MD, MSc, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham. · Pubmed 26136484
2014
  • Divisions of *Endocrinology, Diabetes and Metabolism †Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL ‡Kaiser Permanente Center for Health Research/Northwest, Portland, OR §Kaiser Permanente Center for Health Research/Southeast, Atlanta, GA ∥Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA ¶Division of Clinical Immunology and Rheumatology #Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL. · Pubmed 24984211
Novartis
2015
  • From the Division of Endocrinology, Diabetes and Metabolism, and Division of Clinical Immunology and Rheumatology, and Department of Biostatistics, and Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts; Express Scripts, St. Louis, Missouri; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey; Real Endpoints LLC, Westport, Connecticut, USA.A.H. Warriner, MD, Division of Endocrinology, Diabetes and Metabolism; R.C. Outman, MS, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; J.J. Allison, MD, MS, Department of Quantitative Health Sciences, University of Massachusetts Medical School; J.R. Curtis, MD, MS, MPH, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham; N.J. Markward, PhD, Express Scripts; D.T. Redden, PhD, Department of Biostatistics; M.M. Safford, MD, Division of Preventive Medicine, University of Alabama at Birmingham; E.J. Stanek, PharmD, Novartis Pharmaceuticals Corporation; A.R. Steinkellner, PharmD, Express Scripts* and Real Endpoints LLC; K.G. Saag, MD, MSc, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham. · Pubmed 26136484
3 Other Locations Show
Yearly article counts 001113511221
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.